September 8th 2020
The day cancer treatment ends, a new chapter begins. Some survivors may leave cancer behind and continue life with few or no health problems. Others might have ongoing physical challenges. Some of these might be due to late effects (also called aftereffects) of cancer treatment.
August 31st 2020
By Ryan McDonald
On social media, CURE® recently asked its readers what their thoughts were on the medical use of cannabis. Here, we share some of their responses.
August 21st 2020
By Felicia Mitchell
For a long time, I refused to acknowledge the lingering effects of neuropathy. I found a way to joke about it and told everybody I was clumsy. To acknowledge the elephant in the room, I had to admit I needed to explore balance further.
May 6th 2020
By Katherine Malmo
More cancer centers are introducing virtual reality headsets, which can help relieve anxiety and pain and educate patients about their treatments.
April 28th 2020
By Kathy LaTour
After treatment ends, survivors are left to navigate a new life but that life comes with its new emotions and reactions to the world around us.
April 6th 2020
By Dr. John M. Koval
If you or someone in your home does contract coronavirus, your doctor may suspend or delay your cancer treatments to protect your immune system, an expert from Tampa Bay Radiation Oncology notes.
April 4th 2020
By Brielle Benyon
Patients and their loved ones should take certain precautions to protect themselves from the coronavirus, according to the CDC.
March 31st 2020
The development of an inpatient symptom monitoring intervention, according to researchers, may enhance awareness of patient symptom burden and improve symptom control and health care usage.
March 12th 2020
By Shelly Rosenfeld
March 1st 2020
By Bonnie Annis
Is it possible to determine better cancer treatment with information obtained from a patient’s blood cells? One Israeli company seems to think so.
Can Aprepitant Improve Survival for Women With Breast Cancer?
Reuniting a Family After Multiple Cancer Diagnoses
Expert Oncologist Breaks Down the Current Treatment Landscape of GIST
FDA Grants Breakthrough Therapy Designation to I-DXd in SCLC